University of Washington Foundation
Seattle, Washington, United States
Purpose
to design, produce, characterize and assess the immunogenicity of nanoparticles of multiple, specific symmetries that present the prefusion forms of human respiratory syncytial virus (hRSV) F and human metapneumonia virus (hMPV) F, to poten
Division
Global Health
Date
November 2014
Region Served
GLOBAL
Committed amount
$2,697,432
Grant topic
Discovery and Translational Sciences, Pneumonia & Pandemic Preparedness
Duration (months)
44
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.